Status:
UNKNOWN
Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Collaborating Sponsors:
Geneprodx
Conditions:
Indeterminate Thyroid Cytology
Eligibility:
All Genders
18+ years
Brief Summary
A clinical trial is proposed, to clinically validate, in a US population, the diagnostic performance of a new genetic test (ThyroidPrint). It will determine the nature of thyroid nodules that have bee...
Detailed Description
Thyroid nodules are a very frequent condition reaching up to 30-40% of the adult population. Although most thyroid nodules have little clinical significance, in many cases a fine needle aspirate (FNA)...
Eligibility Criteria
Inclusion
- Patients undergoing FNA of a thyroid nodule.
- Thyroid nodule greater 1cm
- Age greater 18 years old.
Exclusion
- Thyroid nodule greater 1cm
- Patients less than 18 years old,
- Previous history of coagulation disorders and patients.
- Ultrasound evidence of malignant cervical adenopathy.
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2018
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03309631
Start Date
March 1 2016
End Date
June 30 2018
Last Update
October 26 2017
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Avantt Research
Guntersville, Alabama, United States, 35976
2
Stanford University
Palo Alto, California, United States, 94305
3
Lee Moffit Cancer Center
Tampa, Florida, United States
4
Tulane University
New Orleans, Louisiana, United States